Skip to main content

Table 1 Clinical and pathological characteristics of the prostate cancer datasets used in this study

From: A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

  MSKCC
(Taylor et al.)
n = 140
Cambridge
(Ross-Adams et al.)
n = 112
Stockholm
(Ross-Adams et al.)
n = 92
TCGA-PRAD
(TCGA)
n = 490
Age (years)
 Mean 58.04 62   61
 Range 37.3–83.0 41–73   41–78
PSA
 Median 6.15 7.9 7.95  
  < 10 104 80 56  
  ≥ 10 34 31 34  
 Unknown 2 1 2  
Biopsy Gleason
  ≤ 3 + 4 128 77 68  
  ≥ 4 + 3 12 27 22  
 Unknown   8 2  
Surgical Gleason
  ≤ 3 + 4 94 83 56 197
  ≥ 4 + 3 44 29 34 293
 Unknown 2   2  
Extra-capsular ext.     (mri + ct scan combined)
 Y 97 77 42 31
 N 43 35 48 199
 NA/equivocal    2 260
Positive surgical margins
 Y 33 26 42 165
 N 107 86 50 311
 Unknown     14
Recurrence
 Y 36 19 45 91
 N 104 93 47 399
Pathology Stage
 pT2a-c 87 35 47 184
 pT3a-c 46 77 42 290
 pT4 7   3 10
 Unknown     6
  1. The table defines the characteristics of the samples used in this study for each of the datasets